Work

Abstract 7121: CRISPR druggable-genome screen identifies BRD4 as a synergistic vulnerability with the natural product cerberin in pancreatic cancer organoids

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-7121

Authors: Md Shahadat Hossan, Lauryn E. Flannagan, Michela Cadarso, Molly A. Nellen, Ethan S. Lin, Austin Stram, Dustin Rubinstein, Derek Pavelec, Mark E. Berres, Sean Ronnekleiv-Kelly, Jeremy D. Kratz

Institution: University of Wisconsin–Madison

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148702155

Cites:

Cited by:

Related to: